UiPath Inc(NYSE:PATH) analysts stay mostly on the sidelines with concerns for the short-term after the company reported third-quarter financial results Thursday.
The PATH Analysts:Oppenheimer analystBrian Schwartzmaintained a Perform rating on UiPath with no price target.
RBC Capital Markets analystMatthew Hedbergmaintained a Sector Perform rating with a $16 price target.
Truist analystTerry Tillmanmaintained a Hold rating with a $14 price target.
KeyBanc Capital Markets analystJason Celinomaintained a Sector Weight rating with no price target.
JPMorgan analystMark Murphymaintained an Overweight rating and raised the price target from $17 to $18.
Oppenheimer...
Login or create a forever free account to read this news
Sign up/Log in